Joel T Nowak - malecare.org

The Social Security Administration Expedites Some Claims for Disability Benefits, But Not Advanced Prostate Cancer

Social Security Announces Nationwide Launch of Compassionate Allowances Process Will Fast Track Applications For People with Cancers and Rare Diseases Michael J. Astrue, Commissioner of Social Security, today announced the national rollout of the agency’s Compassionate Allowances initiative, a way to expedite the processing of disability claims for applicants whose medical conditions are so severe [...]

By Malecare|2017-10-19T10:56:54-04:00October 29th, 2008|Advanced Prostate Cancer, Advocacy, Financial, Social Security, Uncategorized|0 Comments

Early Versus Deferred Androgen Suppression in the Treatment of Advanced Prostatic Cancer – Which Is Better?

An informative and comprehensive analysis of existing research studies evaluating the merits of early vs. deferred commencement of hormone therapy in men with advanced prostate cancer was recently published. The analysis (Wilt T, Nair B, MacDonald R, Rutks I. Early versus deferred androgen suppression in the treatment of advanced prostatic cancer. Cochrane Database of Systematic [...]

By Malecare|2017-10-19T10:56:55-04:00October 24th, 2008|Advanced Prostate Cancer, Hormone Therapy, Prostate Ponderings, Research, Uncategorized|0 Comments

Prominent Attorney with Terminal Cancer Gets Tysabri After Biogen Idec’s Earlier Denial- Its Implications for Prostate Cancer Treatment

A prominent attorney, Frederick Baron, who is dying of bone marrow cancer, has been granted his wish, to receive the drug Tysabri. After significant wrangling, The FDA and the Mayo Clinic found a legal basis to give him the drug in an emergency situation, even though Tysabri is not approved for any cancers. This decision [...]

By Malecare|2017-10-19T10:56:55-04:00October 22nd, 2008|Advanced Prostate Cancer, Advocacy, Clinical Trials, Drugs & Treatments, Uncategorized|0 Comments

Interim Phase II Results Support A Positive result Of CB7630 (Abiraterone Acetate) In Advanced Prostate Cancer Patients

Today, Cougar Biotechnology, Inc. (NASDAQ:CGRB) unveiled the results from its ongoing Phase II clinical trial drug CB7630 (abiraterone acetate). The data was presented at the Prostate Cancer Foundation Scientific Retreat in Lake Tahoe, Nevada. The clinical trial, which is centered at the M.D. Anderson Cancer Center in Texas and was designed to look at the [...]

By Malecare|2017-10-19T10:56:55-04:00October 21st, 2008|Advanced Prostate Cancer, Chemo Therapy, Clinical Trials, Drugs & Treatments, Research, Uncategorized|0 Comments

Understanding Bone Complications From Metastases

As advanced prostate cancer progresses it becomes inevitable that we will develop bone metastases. The treatments available are designed to slow disease progression, to relieve pain and to avoid the complications that result from bones being weakened by the cancer. Weakened bones become very susceptible to fractures, with prostate cancer the most likely sight for [...]

By Malecare|2017-10-19T10:56:56-04:00October 20th, 2008|Advanced Prostate Cancer, Metastases, Uncategorized, Understanding APC|2 Comments